Cargando…

Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour

Tapping into the ability of engineered mesenchymal stem cells (MSCs) to mobilise into the tumour has expanded the scope of cancer treatment. Engineered MSCs expressing tumour necrosis factor (TNF)-related apoptosis inducing ligand (MSC-TRAIL) could serve as a platform for an efficient and targeted f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaik Fakiruddin, Kamal, Ghazalli, Nadiah, Lim, Moon Nian, Zakaria, Zubaidah, Abdullah, Syahril
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121609/ https://www.ncbi.nlm.nih.gov/pubmed/30060445 http://dx.doi.org/10.3390/ijms19082188

Ejemplares similares

Targeting of CD133+ Cancer Stem Cells by Mesenchymal Stem Cell Expressing TRAIL Reveals a Prospective Role of Apoptotic Gene Regulation in Non-Small Cell Lung Cancer
por: Shaik Fakiruddin, Kamal, et al.
Publicado: (2019)

Chemo-Sensitization of CD133+ Cancer Stem Cell Enhances the Effect of Mesenchymal Stem Cell Expressing TRAIL in Non-Small Cell Lung Cancer Cell Lines
por: Fakiruddin, Kamal Shaik, et al.
Publicado: (2021)

Nucleofection optimization and in vitro anti-tumourigenic effect of TRAIL-expressing human adipose-derived mesenchymal stromal cells
por: Fakiruddin, Kamal Shaik, et al.
Publicado: (2014)

Systematic review and meta-analysis of mesenchymal stromal/stem cells as strategical means for the treatment of COVID-19
por: Taufiq, Hannah, et al.
Publicado: (2023)

Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines
por: BAHARUDDIN, PUTERI, et al.
Publicado: (2016)

Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells
por: Zakaria, Norashikin, et al.
Publicado: (2015)

Novel triple-positive markers identified in human non-small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics
por: Satar, Nazilah Abdul, et al.
Publicado: (2018)

Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis
por: Marini, Patrizia, et al.
Publicado: (2005)

Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton’s jelly mesenchymal stromal cells
por: Rengasamy, Mathiyazhagan, et al.
Publicado: (2017)

The Effects of Lentivirus-Mediated Gene Silencing of RARβ on the Stemness Capability of Non-Small Cell Lung Cancer
por: Abu Halim, Noor Hanis, et al.
Publicado: (2021)

Limited expression of non-integrating CpG-free plasmid is associated with increased nucleosome enrichment
por: Habib, Omar, et al.
Publicado: (2020)

A Comparative Study of Non-Viral Gene Delivery Techniques to Human Adipose-Derived Mesenchymal Stem Cell
por: Halim, Nur Shuhaidatul Sarmiza Abdul, et al.
Publicado: (2014)

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma
por: Sage, Elizabeth K, et al.
Publicado: (2014)

Cinnarizine and flunarizine as radiation sensitisers in two murine tumours.
por: Wood, P. J., et al.
Publicado: (1988)

Inhibition of lysis of sensitised tumour cells in the presence of complement.
por: Hartveit, F.
Publicado: (1965)

A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents
por: Arizono, Y, et al.
Publicado: (2003)

Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
por: Meijer, A, et al.
Publicado: (2013)

TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt
por: Szegezdi, E, et al.
Publicado: (2006)

Activation of the aryl hydrocarbon receptor sensitises human keratinocytes for CD95L- and TRAIL-induced apoptosis
por: Stolpmann, K, et al.
Publicado: (2012)

Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model
por: Mohr, Andrea, et al.
Publicado: (2008)

IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis
por: Perimenis, Philippos, et al.
Publicado: (2016)

Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism
por: Bullenkamp, J, et al.
Publicado: (2014)

Ex vivo expanded SSEA-4+ human limbal stromal cells are multipotent and do not express other embryonic stem cell markers
por: Lim, Moon Nian, et al.
Publicado: (2012)

Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress
por: Herbert, Katharine J., et al.
Publicado: (2020)

Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy
por: Shapiro, Daniel D., et al.
Publicado: (2023)

Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis
por: Duiker, E W, et al.
Publicado: (2011)

The anticancer drug mithramycin A sensitises tumour cells to apoptosis induced by tumour necrosis factor (TNF)
por: Duverger, V, et al.
Publicado: (2004)

α-Tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-κB activation
por: Dalen, H, et al.
Publicado: (2003)

Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL
por: Eustace, Alex J, et al.
Publicado: (2018)

Cancer stem cells as key drivers of tumour progression
por: Ayob, Ain Zubaidah, et al.
Publicado: (2018)

An added dimension to tumour TRAIL sensitivity
por: Healy, Sandra, et al.
Publicado: (2015)

TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population
por: Loebinger, M R, et al.
Publicado: (2010)

Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction
por: Lickliter, J D, et al.
Publicado: (2007)

Radiation-Sensitising Effects of Antennapedia Proteins (ANTP)-SmacN7 on Tumour Cells
por: Du, Li Qing, et al.
Publicado: (2013)

Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In Situ
por: Reagan, Michaela R., et al.
Publicado: (2012)

Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa
por: de Bruijn, M T, et al.
Publicado: (2010)

ATM Kinase Inhibition Preferentially Sensitises PTEN-Deficient Prostate Tumour Cells to Ionising Radiation
por: Hanna, Conor, et al.
Publicado: (2020)

Tumour cells are sensitised to ferroptosis via RB1CC1‐mediated transcriptional reprogramming
por: Xue, Xiangfei, et al.
Publicado: (2022)

HLA sensitisation: can it be prevented?
por: Rees, Lesley, et al.
Publicado: (2014)

Sensitisation patterns to tomato seed
por: González, Miguel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_btp7lv17i9g6fss8cehgjqfvsc